Oxidative stress, redox, and the tumor microenvironment

This publication has 30 references indexed in Scilit:

• Study of in vitro and in vivo effects of the piperidine nitroxide Tempol—a potential new therapeutic agent for gliomas
  European Journal Of Cancer, 2003
• Thioredoxin reductase regulates AP-1 activity as well as thioredoxin nuclear localization via active cysteines in response to ionizing radiation
  Oncogene, 2002
• Tumour cell radiosensitization using constitutive (CMV) and radiation inducible (WAF1) promoters to drive the iNOS gene: a novel suicide gene therapy
  Gene Therapy, 2002
• Anticancer Therapy by Overexpression of Superoxide Dismutase
  Antioxidants and Redox Signaling, 2001
• Nucleoredoxin, Glutaredoxin, and Thioredoxin Differentially Regulate NF-κB, AP-1, and CREB Activation in HEK293 Cells
  Biochemical and Biophysical Research Communications, 2000
• Distinct Roles of Thioredoxin in the Cytoplasm and in the Nucleus
  Journal of Biological Chemistry, 1999
• Intracellular oxidation/reduction status in the regulation of transcription factors NF-κB and AP-1
  Toxicology Letters, 1999
• Evaluation of Tempol Radioprotection in a Murine Tumor Model
  Free Radical Biology & Medicine, 1997
• Nitric oxide regulates mitochondrial respiration and cell functions by inhibiting cytochrome oxidase
  FEBS Letters, 1995
• The relationship of SR-2508 sensitizer enhancement ratio to cellular glutathione levels in human tumor cell lines
  International Journal of Radiation Oncology*Biology*Physics, 1986